stemming en cognitie NAP
Conditions
Interventions
3 different conditions
1. Placebo: 4 x capsules filled with Avicel PH-101, Ph Eur (Fluka)
2. High theobromine (450 mg) and caffeine (60 mg): 3 x capsule with theobromine
(150 mg) + 1 x capsule with
Sponsors
Unilever
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Age at start of the study >= 18 and = 18.5 and
Exclusion criteria
Exclusion criteria: Being an Unilever employee Consumes more than 250 mg caffeine daily Using or planning to use any medically prescribed diet or weight-loss diet or making any attempt to control diet at screening and during the entire study. Reported intense sporting activities > 10 h/w Subjects who undergoing medical treatment that may interfere with the study outcome. Use of systemic antibiotics in the period of 3 months prior to the study Reported participation in another biomedical study 1 month before the start or during the study. Reported intolerance or allergy for one of test products or standardized meal The habit of smoking during the past half year or using nicotine containing medicines during the past month Reported lactating (or lactating 160 mmHg and/ or diastolic blood pressure > 95 mmHg, irregular heart rate and/or heart rate > 100 bpm. Eligibility of subjects with a heart rate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Explicit and implicit mood Concentration and attention | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure Personality scores | — |
Countries
Netherlands
Outcome results
None listed